April 6, 2024 Patients with heart failure who had a small shunt inserted between the hearts left and right atria did not see any significant benefits overall compared with those who received a placebo procedure after a median of 22 months follow-up, in a study presented at the American College of Cardiologys Annual Scientific Session.
The trial, called RELIEVE-HF, is the first randomized placebo-procedure controlled trial of interatrial shunting that included patients with both major types of heart failure: heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers.
Gregg Stone, MD
When you examine the outcomes in patients with heart failure across a broad range of left ventricular ejection fraction, the Ventura interatrial shunt was extremely safe but did not improve outcomes compared with no treatment. However, in a prespecified analysis, data suggest that the shunt may be beneficial in patients with HFrEF and worsen outcomes in patients with HFpEF, said Gregg Stone, MD, professor of cardiology and population health sciences at Icahn School of Medicine at Mount Sinai in New York and the studys first author. We believe further studies are warranted to confirm the benefits we observed in patients with reduced ejection fraction.
Heart failure is a condition in which the heart becomes too weak or stiff to effectively pump blood, leading to fatigue, organ damage, shortness of breath and an increased risk of life-threatening cardiovascular events. In HFrEF, the heart muscle becomes weak and does not squeeze as hard as it should. In HFpEF, the left ventricle becomes stiff and does not properly fill with blood.
The Ventura shunt is one of several interatrial devices being tested to aid in the treatment of heart failure. It is designed to form a small connection or passage between the left and right atria to allow blood to leave the left atriumespecially as left atrial pressure risesthus reducing the pressure in the left atrium and the lungs. High left atrial pressure is a primary cause of shortness of breath and hospitalizations related to heart failure.
The trial randomized 508 patients at 94 sites in North America, Europe, Israel, Australia and New Zealand. All participants had symptomatic heart failure despite taking medications at maximally tolerated doses. About 40% of participants had HFrEF and 60% had HFpEF.
Participants were randomly assigned to undergo a procedure to insert the Ventura shunt or a placebo procedure in which a script was followed with all the same protocols to mask patients as to whether the shunt was inserted. Operators were aware of which procedure each patient received but patients, their families and the rest of the medical teams taking care of the patient after the procedure were not. Researchers tracked outcomes in each participant for at least one year and up to two years.
The results showed no significant difference between groups in terms of the trials primary endpoint, a hierarchical composite ranking of death from any cause; heart transplant or left ventricular assist device; heart failure hospitalizations; worsening of outpatient heart failure events; and change in quality of life, as measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ). This hierarchical composite approach for assessing efficacy allows diverse types of outcomes to be incorporated in ranked fashion into an overall win ratio reflecting the overall outcome of a drug or device.
In a pre-planned analysis focused on heart failure type, patients with HFrEF who received the shunt were found to have improvements across all outcomes assessed (especially fewer hospitalizations for heart failure), while those with HFpEF who received the shunt were found to have increased rates of death and heart failure hospitalizations. This difference could be attributed to the greater compliance or flexibility of the heart muscle with HFrEF, potentially allowing it to more easily accommodate the extra blood flowing into the right atrium, Stone said.
There were no device-related or procedure-related major adverse cardiovascular or neurologic events in either group during the duration of the trial.
Surprisingly, a marked improvement in quality of life as measured with KCCQ was observed across all groupsincluding those who received a placebo procedure, both with HFrEF and HFpEFsuggesting that the metric may not be a reliable indicator for quality-of-life outcomes in this context, Stone said.
There was a tremendous placebo effect, he said. These observations, especially the fact that quality of life improved in HFpEF patients who were more likely to be hospitalized for heart failure and had reduced survival after shunt treatment, raise questions about the interpretation of this quality-of-life measure in these kinds of trials.
Although the observed differences in outcomes among people with different types of heart failure may inform future research and development for interatrial devices, the researchers said that the trial was not powered to show differences in the two types of heart failure. As such, these results should be considered exploratory. They also said that the results may not be applicable to other interatrial shunts beyond the Ventura shunt.
The study was funded by V-Wave Medical.
For more information: http://www.acc.org
Find more ACC24 conference coverage here
Visit link:
- Applications of Nanotechnology in the Field of Cardiology - Cureus - April 15th, 2024 [April 15th, 2024]
- Tri-City Cardiology's Ambulatory Surgical Center (ASC) Leads the Way in Revolutionizing Heart Failure Management - PR Newswire - April 15th, 2024 [April 15th, 2024]
- Watchdog group calls out risks associated with private equity in cardiology, other specialties - Cardiovascular Business - April 15th, 2024 [April 15th, 2024]
- Heart health: Cardiologist shares impact of advanced wearable technology on patient monitoring - News9 LIVE - April 15th, 2024 [April 15th, 2024]
- Apr 12 2024 This Week in Cardiology - Medscape - April 15th, 2024 [April 15th, 2024]
- TAVR Found Non-Inferior to SAVR for Low-Risk Patients - Diagnostic and Interventional Cardiology - April 15th, 2024 [April 15th, 2024]
- Telemedicine Strategy After MI Scores a Win in TELE-ACS - TCTMD - April 15th, 2024 [April 15th, 2024]
- Global Interventional Cardiology Devices Market Projected to Reach $21.9 Billion by 2030 - GlobeNewswire - April 15th, 2024 [April 15th, 2024]
- SGLT-2 Inhibitors Show Mixed Results After Heart Attack - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1, A Building Block of HDL Cholesterol - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Association of Black Cardiologists' "We Are The Faces" Campaign Unveils New Videos for Black Maternal Health Week - PR Newswire - April 7th, 2024 [April 7th, 2024]
- UNC Hospitals Performs First Transcatheter Tricuspid Valve Replacement in North Carolina | Newsroom - UNC Health and UNC School of Medicine - April 7th, 2024 [April 7th, 2024]
- Cardiawave is Presenting the 30-day Follow-up Results from its Valvosoft Pivotal Study on the Teatment of Severe ... - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- Real-world Evidence at the American College of Cardiology Scientific Session ACC.24 to Demonstrate Positive Impact ... - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24 - Diagnostic and Interventional... - April 7th, 2024 [April 7th, 2024]
- ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- Medicare drops AUC requirement for advanced imaging, ASNC celebrates - Cardiovascular Business - April 7th, 2024 [April 7th, 2024]
- Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions - Yale School of Medicine - April 7th, 2024 [April 7th, 2024]
- Getting Too Little Sleep Linked to High Blood Pressure - Diagnostic and Interventional Cardiology - April 7th, 2024 [April 7th, 2024]
- What's Going to Be Hot at ACC 2024 - TCTMD - April 7th, 2024 [April 7th, 2024]
- E-cigarette use linked to increased risk of heart failure, large study finds - News-Medical.Net - April 7th, 2024 [April 7th, 2024]
- Osso VR and ACC to Develop Cardiac Procedure Training with VR - HIT Consultant - April 7th, 2024 [April 7th, 2024]
- Kapil Yadav, M.D., Joins UAMS to Lead Nuclear Cardiology and Vascular Medicine Program - UAMS News - March 19th, 2024 [March 19th, 2024]
- Doctors form new coalition focused on reducing private equity's role in cardiology, other healthcare specialties - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Beth Israel Deaconess Medical Center cardiologist to be honored by American Heart Association - American Heart Association - March 19th, 2024 [March 19th, 2024]
- March 19 Doctors on Call Will Focus on Cardiology - KRSL - March 19th, 2024 [March 19th, 2024]
- Cardiologist shares his long journey from Libya to United States - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Cardiologists share historic research that led to FDA's long-awaited approval of coronary DCB - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Most physicians think private equity is bad for healthcare - Cardiovascular Business - March 19th, 2024 [March 19th, 2024]
- Meth-Related Cardiomyopathy: Where the Biggest Clusters Are - Medpage Today - March 19th, 2024 [March 19th, 2024]
- Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports - Diagnostic and Interventional Cardiology - March 19th, 2024 [March 19th, 2024]
- SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement - Diagnostic and Interventional Cardiology - March 19th, 2024 [March 19th, 2024]
- Intravascular imaging during PCI in heart disease patients improves survival, reduces adverse outcomes - News-Medical.Net - March 19th, 2024 [March 19th, 2024]
- PA Martine Altieri Brings an Obesity Medicine Clinic to Her Cardiology Patients - AAPA - March 11th, 2024 [March 11th, 2024]
- WEGOVY APPROVED FOR HEART RISK: U-Mich cardiology, obesity medicine experts available for interview - Newswise - March 11th, 2024 [March 11th, 2024]
- AHA Sums Up AI's Potential in Cardiology, but Also the Hurdles Ahead - TCTMD - March 11th, 2024 [March 11th, 2024]
- Houston cardiology-focused tech platform exits to private equity, plans to scale - InnovationMap - March 11th, 2024 [March 11th, 2024]
- The Daylight Saving Time Health Effects You Might Not Be Expecting, According to a Cardiology Specialist (Exclusive) - PEOPLE - March 11th, 2024 [March 11th, 2024]
- How a big CMS update on carotid stenting could impact interventional cardiology - Cardiovascular Business - March 11th, 2024 [March 11th, 2024]
- Global Cardiology Medical Imaging Informatics Market - Cloud-powered Telecardiology to Improve Access to Healthcare - PR Newswire - March 11th, 2024 [March 11th, 2024]
- Valley Health cardiologist talks regional heart health | Nvdaily | nvdaily.com - Northern Virginia Daily - March 11th, 2024 [March 11th, 2024]
- With the correct research, AI in pediatric cardiology has great potential - Contemporary Pediatrics - March 11th, 2024 [March 11th, 2024]
- Top in cardiology: Cannabis use, heat exposure associated with higher stroke risk - Healio - March 11th, 2024 [March 11th, 2024]
- Researcher promotes subsidies to bring cardiac care closer to home in rural areas - Montana Right Now - March 11th, 2024 [March 11th, 2024]
- Cardiologist aims to improve care, reduce costly air transport - The Taos News - March 11th, 2024 [March 11th, 2024]
- Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk ... - Diagnostic and... - February 29th, 2024 [February 29th, 2024]
- Even Modest Lp(a) Elevations Bode Poorly for Cardiovascular Health - Medpage Today - February 29th, 2024 [February 29th, 2024]
- Bojangles surprises CMC cardiology team with heart-shaped biscuits for Heart Month - wpde.com - February 29th, 2024 [February 29th, 2024]
- Health Beat: Local cardiologists raise awareness about heart disease prevention - Iredell Free News - February 29th, 2024 [February 29th, 2024]
- Miami Valves 2024 Showcases Innovations in Structural Heart and Cardiovascular Care - InventUM - University of Miami - February 29th, 2024 [February 29th, 2024]
- Cardiology Specialists Keep a Pulse on Adults Born with Heart Defects - Checkup Newsroom - February 29th, 2024 [February 29th, 2024]
- A Living Legend of Health Equity in Stroke and Heart Disease - Penn Medicine - February 29th, 2024 [February 29th, 2024]
- Cardiologist at heart of TAVR controversy loses hospital privileges due to 'disruptive,' 'inexplicable' behavior - Cardiovascular Business - February 29th, 2024 [February 29th, 2024]
- Integration of pharmacist-led pharmacogenomics testing in cardiology clinical practice - Healio - February 29th, 2024 [February 29th, 2024]
- Foiled Theft of Medicines at Punjab Institute of Cardiology Highlights Organized Crime Concerns - BNN Breaking - February 29th, 2024 [February 29th, 2024]
- Feb 23 2024 This Week in Cardiology - Medscape - February 29th, 2024 [February 29th, 2024]
- Hospital doesnt miss a beat when it comes to cardiac care - Martha's Vineyard Times - February 29th, 2024 [February 29th, 2024]
- Cardiologist on the beat for healthy hearts | News, Sports, Jobs - Marietta Times - February 29th, 2024 [February 29th, 2024]
- One of few females in her field, Dr. Sheth focuses on educating women about heart health - Chicago Tribune - February 29th, 2024 [February 29th, 2024]
- URMC Hosts 'Heartbeat of Upson' Celebration | Lifestyle | upsonbeacon.com - upsonbeacon.com - February 29th, 2024 [February 29th, 2024]
- WVU, Valley Health offer pediatric cardiology in Tri-State | Special Sections | loganbanner.com - The Logan Banner - February 29th, 2024 [February 29th, 2024]
- First patient treated using A-Flux Reducer interventional system for angina - Cardiac Rhythm News - February 29th, 2024 [February 29th, 2024]
- Happy Holidays from the Diagnostic and Interventional Cardiology Team - Diagnostic and Interventional Cardiology - December 31st, 2023 [December 31st, 2023]
- 7 New Year's Resolutions for Heart Health From Cardiologists - Livestrong - December 31st, 2023 [December 31st, 2023]
- Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation ... - Diagnostic and Interventional... - December 31st, 2023 [December 31st, 2023]
- Smidt Heart Institute at Cedars-Sinai opens Aortic Surveillance Clinic for patients with enlarged aortas - News-Medical.Net - December 31st, 2023 [December 31st, 2023]
- Creatinine and Cystatin C-based GFR Estimation in HF Mortality - Physician's Weekly - December 31st, 2023 [December 31st, 2023]
- Holidays linked to surge in heart attacks, warns cardiology chief ahead of Christmas - WTOV Steubenville - December 22nd, 2023 [December 22nd, 2023]
- 5 trends in cardiology to watch - Harvard Health - December 22nd, 2023 [December 22nd, 2023]
- Top Policy and Practice News for Cardiologists in 2023 - TCTMD - December 22nd, 2023 [December 22nd, 2023]
- Colchicine Not the Answer for Recurring Arrhythmias After Ablation - Medpage Today - December 22nd, 2023 [December 22nd, 2023]
- Chamber Cardio Launches Innovative Value-Based Cardiology Care Platform with Early Success - PR Newswire - December 22nd, 2023 [December 22nd, 2023]
- Drinking in moderation can help avoid 'holiday heart syndrome' - UT Southwestern - December 22nd, 2023 [December 22nd, 2023]
- Top Cardiology Trials and Studies of 2023: Insights and Breakthroughs - Medriva - December 22nd, 2023 [December 22nd, 2023]
- Overview of Major Cardiology Trials in 2023 - Medriva - December 22nd, 2023 [December 22nd, 2023]
- New drugs, updated treatment strategies: 5 important trends in cardiology from an eventful 2023 - Cardiovascular Business - December 22nd, 2023 [December 22nd, 2023]
- The Top Cardiology Trials of 2023 - Medscape - December 22nd, 2023 [December 22nd, 2023]
- Cardiologists' Holiday Wish: Medicare Pay Cuts Roasting on an Open Fire - TCTMD - December 22nd, 2023 [December 22nd, 2023]
- Dec 15 2023 This Week in Cardiology - Medscape - December 22nd, 2023 [December 22nd, 2023]